Related Experiment Video
Updated: May 12, 2026
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
[Metformin effect on urethane-induced tumorigenesis in mice]
Voprosy Onkologii
|April 24, 2013
Summary
Metformin demonstrated a tumor-inhibitory effect in mice exposed to urethane. This study provides the first evidence of metformin
Area of Science:
- Oncology
- Pharmacology
- Toxicology
Context:
- Urethane is a known carcinogen used to induce tumors in mice.
- Metformin is a widely used antidiabetic drug with potential anticancer properties.
- This study investigates the efficacy of metformin in preventing urethane-induced tumors.
Purpose:
- To evaluate the tumor-inhibitory effect of metformin in a mouse model.
- To assess the impact of metformin on the development of lung adenomas and thymic lymphomas.
- To provide initial evidence for metformin's potential as an anticancer agent.
Summary:
- Male 129/Sv mice received urethane injection followed by metformin in drinking water for 26 weeks.
- Control mice received only urethane and water.
- Tumor incidence was lower in the metformin-treated group (80.7%) compared to controls (96.7%), with a significant difference (p<0.05).
- Lung adenoma development was also reduced in the metformin group (77%) versus controls (90%), though not statistically significant (p=0.119).
Impact:
- This research presents the first evidence of metformin's tumor-inhibitory effects in a chemically induced cancer model.
- Findings suggest metformin may have a role in cancer chemoprevention.
- Further research is warranted to explore metformin's mechanisms and clinical applications in oncology.
